Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Greist

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|September 18, 2009
Assessing onset of treatment benefit in depression and anxiety: conceptual considerationsEugene M Laska, Craig H Mallinckrodt, Jim C Mundt, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter studyMadelaine M Wohlreich, Curtis G Wiltse, Durisala Desaiah, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trialsHeidi K Moore, James C Mundt, Jack G Modell, et al.
Journal of Medical Internet Research|November 19, 2019
Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled TrialMark B Schure, Janet C Lindow, John H Greist, et al.
The Journal of Clinical Psychiatry|June 26, 2003
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander, Lorrin M Koran, Wayne K Goodman, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist, Borwin Bandelow, Eric Hollander, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of panic disorderMark H Pollack, Christer Allgulander, Borwin Bandelow, et al.
International Clinical Psychopharmacology|September 30, 2005
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind studyKenneth A Kobak, Leslie V H Taylor, Alexander Bystritsky, et al.
The Journal of Clinical Psychiatry|March 5, 2002
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a controlJohn H Greist, Isaac M Marks, Lee Baer, et al.
The Journal of Clinical Psychiatry|December 29, 2007
A comparison of initial duloxetine dosing strategies in patients with major depressive disorderVirgil G Whitmyer, David L Dunner, Susan G Kornstein, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|September 18, 2009
Assessing onset of treatment benefit in depression and anxiety: conceptual considerationsEugene M Laska, Craig H Mallinckrodt, Jim C Mundt, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter studyMadelaine M Wohlreich, Curtis G Wiltse, Durisala Desaiah, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trialsHeidi K Moore, James C Mundt, Jack G Modell, et al.
Journal of Medical Internet Research|November 19, 2019
Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled TrialMark B Schure, Janet C Lindow, John H Greist, et al.
The Journal of Clinical Psychiatry|June 26, 2003
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander, Lorrin M Koran, Wayne K Goodman, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist, Borwin Bandelow, Eric Hollander, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of panic disorderMark H Pollack, Christer Allgulander, Borwin Bandelow, et al.
International Clinical Psychopharmacology|September 30, 2005
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind studyKenneth A Kobak, Leslie V H Taylor, Alexander Bystritsky, et al.
The Journal of Clinical Psychiatry|March 5, 2002
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a controlJohn H Greist, Isaac M Marks, Lee Baer, et al.
The Journal of Clinical Psychiatry|December 29, 2007
A comparison of initial duloxetine dosing strategies in patients with major depressive disorderVirgil G Whitmyer, David L Dunner, Susan G Kornstein, et al.
Pageof 4